RecruitingNot ApplicableNCT07399977

Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism

A Nonrandomized Trial Using DNA Liquid Biopsies to Guide Anticoagulation For Patients With Cancer-Associated Thromboembolism

Sponsor

Memorial Sloan Kettering Cancer Center

Enrollment

259 participants

Start Date

Jan 30, 2026

Study Type

INTERVENTIONAL

Conditions

Deep Venous Thrombosis Venous Thromboembolism

Summary

The purpose of this study is to find out whether a software tool, ctDNA/VTE (Venous Thromboembolism) risk score model, is an effective way to predict the likelihood of VTE coming back in people who have received anticoagulant treatment.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying MSK-ACCESS and ctDNA/VTE Risk Score: for people with deep venous thrombosis and venous thromboembolism. The study is currently recruiting participants at 8 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTMSK-ACCESS

MSK-ACCESS is a ctDNA sequencing assay

DIAGNOSTIC_TESTctDNA/VTE Risk Score:

Machine learning Venous Thromboembolism/VTE risk score mode

Locations(8)

Memorial Sloan Kettering Cancer Center Basking Ridge (All Protocol Activities)

Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (All Protocol Activities)

Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (All Protocol Activities)

Montvale, New Jersey, United States

Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities)

Commack, New York, United States

Memorial Sloan Kettering Westchester (All Protocol Activities)

Harrison, New York, United States

Memorial Sloan Kettering Cancer Center (All Protocol Activites)

New York, New York, United States

Memorial Sloan Kettering Nassau (All protocol activities)

Rockville Centre, New York, United States

Royal North Shore Hospital, Australia

Sydney, Australia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07399977

Related Trials

DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis

NCT0570191764 locations

Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial)

NCT064406944 locations

Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism

NCT063938687 locations

Pulmonary Embolism in Patients With Acute Heart Failure (PEHF Study)

NCT0749966110 locations

Aspiration Thrombectomy Using the Symphony or Prodigy System

NCT073504996 locations